(NASDAQ: FTRE) Fortrea Holdings's forecast annual revenue growth rate of 3.35% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 32.66%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12%.
Fortrea Holdings's revenue in 2026 is $2,666,700,000.On average, 15 Wall Street analysts forecast FTRE's revenue for 2026 to be $263,638,000,000, with the lowest FTRE revenue forecast at $252,058,000,000, and the highest FTRE revenue forecast at $272,419,500,000. On average, 15 Wall Street analysts forecast FTRE's revenue for 2027 to be $272,226,500,000, with the lowest FTRE revenue forecast at $258,041,000,000, and the highest FTRE revenue forecast at $283,710,000,000.
In 2028, FTRE is forecast to generate $284,868,000,000 in revenue, with the lowest revenue forecast at $269,042,000,000 and the highest revenue forecast at $300,694,000,000.